231
TITLE: SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
AUTHORS: Vieira, FQ; Costa Pinheiro, P; Almeida Rios, D; Graa, I; Monteiro Reis, S; Simoes Sousa, S; Carneiro, I; Sousa, EJ; Godinho, MI; Baltazar, F; Henrique, R ; Carmen Jerónimo ;
PUBLISHED: 2015, SOURCE: ONCOTARGET, VOLUME: 6, ISSUE: 15
INDEXED IN: Scopus WOS CrossRef Handle
232
TITLE: SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets cyclin D2 through H4K20me3
AUTHORS: Vieira, FQ; Costa Pinheiro, P; Almeida Rios, D; Graca, I; Monteiro Reis, S; Simoes Sousa, S; Carneiro, I; Sousa, EJ; Godinho, MI; Baltazar, F; Henrique, R ; Carmen Jerónimo ;
PUBLISHED: 2015, SOURCE: Oncotarget, VOLUME: 6, ISSUE: 15
INDEXED IN: Scopus Handle
IN MY: ORCID
233
TITLE: Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements
AUTHORS: Santos, J; Mesquita, D; Barros Silva, JD; Carmen Jerónimo ; Henrique, R ; Morais, A; Paulo, P; Teixeira, MR ;
PUBLISHED: 2015, SOURCE: Oncoscience, VOLUME: 2, ISSUE: 5
INDEXED IN: Scopus CrossRef: 10
234
TITLE: Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation  Full Text
AUTHORS: Sara Monteiro Reis; Luis Leca; Mafalda Almeida; Luis Antunes; Paula Monteiro; Paula C Dias; Antonio Morais; Jorge Oliveira; Rui Henrique ; Carmen Jerónimo ;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 50, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 38
236
TITLE: Anti-neoplastic properties of hydralazine in prostate cancer
AUTHORS: Ines Graca; Elsa J Sousa; Pedro Costa Pinheiro; Filipa Q Vieira; Jorge Torres Ferreira; Maria Gabriela Martins; Rui Henrique ; Carmen Jerónimo ;
PUBLISHED: 2014, SOURCE: ONCOTARGET, VOLUME: 5, ISSUE: 15
INDEXED IN: Scopus WOS
237
TITLE: Anti-neoplastic properties of hydralazine in prostate cancer
AUTHORS: Inês Graça; Elsa J Sousa; Pedro Costa-Pinheiro; Filipa Q Vieira; Jorge Torres-Ferreira; Maria Gabriela Martins; Rui Henrique; Carmen Jerónimo ;
PUBLISHED: 2014, SOURCE: Oncotarget, VOLUME: 5, ISSUE: 15
INDEXED IN: CrossRef: 47 Handle
238
TITLE: Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells
AUTHORS: Graca, I; Sousa, EJ; Baptista, T; Almeida, M; Ramalho Carvalho, J; Palmeira, C; Henrique, R ; Carmen Jerónimo ;
PUBLISHED: 2014, SOURCE: CURRENT PHARMACEUTICAL DESIGN, VOLUME: 20, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef Handle
239
TITLE: Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer
AUTHORS: Pedro Costa Pinheiro; Hiten R H Patel; Rui Henrique ; Carmen Jerónimo ;
PUBLISHED: 2014, SOURCE: EXPERT REVIEW OF ANTICANCER THERAPY, VOLUME: 14, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 6
240
TITLE: Biopsy sampling and histopathological markers for diagnosis of prostate cancer
AUTHORS: Angelo Rodrigues; Rui Freitas; Pedro Nogueira Silva; Carmen Jerónimo ; Rui Henrique ;
PUBLISHED: 2014, SOURCE: EXPERT REVIEW OF ANTICANCER THERAPY, VOLUME: 14, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 3
Page 24 of 35. Total results: 343.